Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia. | Int J Gen Med | 2022 | 35308573 | PubTator, text mining | PubMed |
| The colonic pathogen Entamoeba histolytica activates caspase-4/1 that cleaves the pore-forming protein gasdermin D to regulate IL-1β secretion. | PLoS Pathog | 2022 | 35303042 | PubTator, text mining | PubMed |
| Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma. | Sci Rep | 2022 | 35296768 | PubTator, text mining | PubMed |
| TGFα-EGFR pathway in breast carcinogenesis, association with WWOX expression and estrogen activation. | J Appl Genet | 2022 | 35290621 | PubTator, text mining | PubMed |
| AhR promotes phosphorylation of ARNT isoform 1 in human T cell malignancies as a switch for optimal AhR activity. | Proc Natl Acad Sci U S A | 2022 | 35290121 | PubTator, text mining | PubMed |
| ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis. | iScience | 2022 | 35287354 | PubTator, text mining | PubMed |
| Tyrosine phosphatase SHP2 exacerbates psoriasis-like skin inflammation in mice via ERK5-dependent NETosis. | MedComm (2020) | 2022 | 35281792 | PubTator, text mining | PubMed |
| SARS-CoV-2 Induces Cytokine Responses in Human Basophils. | Front Immunol | 2022 | 35280992 | PubTator, text mining | PubMed |
| In vitro evaluation of the pogostone effects on the expression of PTEN and DACT1 tumor suppressor genes, cell cycle, and apoptosis in ovarian cancer cell line. | Res Pharm Sci | 2022 | 35280836 | PubTator, text mining | PubMed |
| Infiltration of inflammatory macrophages and neutrophils and widespread pyroptosis in lung drive influenza lethality in nonhuman primates. | PLoS Pathog | 2022 | 35271686 | PubTator, text mining | PubMed |
| Actions of Bisphenol A on Different Feto-Maternal Compartments Contributing to Preterm Birth. | Int J Mol Sci | 2022 | 35269554 | PubTator, text mining | PubMed |
| Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. | Front Immunol | 2022 | 35265086 | PubTator, text mining | PubMed |
| Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease. | J Nanobiotechnology | 2022 | 35264192 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Prognostic Value of Pyroptosis-Related Genes and Its Effect on Immune Cell Infiltration in Pancreatic Adenocarcinoma. | Int J Gen Med | 2022 | 35256857 | PubTator, text mining | PubMed |
| Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes. | BMC Med Genomics | 2022 | 35255915 | PubTator, text mining | PubMed |
| Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor. | Cancer Discov | 2022 | 35254416 | PubTator, text mining | PubMed |
| A narrative review of pyrolysis and its role in ulcerative colitis. | Eur Rev Med Pharmacol Sci | 2022 | 35253171 | PubTator, text mining | PubMed |
| In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies. | J Immunother Cancer | 2022 | 35246475 | PubTator, text mining | PubMed |
| Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer. | J Transl Med | 2022 | 35246158 | PubTator, text mining | PubMed |
| Programmed cell death: the pathways to severe COVID-19? | Biochem J | 2022 | 35244141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=50